Phorbol ester tumour promoter mediated altered expression and regulation of matrix metalloproteinase-2 in a H-ras transformed cell line capable of benign tumour formation.
The matrix metalloproteinases (MMPs) are thought to play key roles in tumour formation and malignant progression. The present study demonstrates alterations in the regulation of matrix metalloproteinase-2 (MMP-2) expression in response to the phorbol ester tumour promoter, PMA, in a H-ras transformed cell line, NR3, which is capable of benign tumour formation. PMA treatment of NR3 cells resulted in decreased expression of MMP-2 mRNA levels. Following a lag period, an accompanying change in gelatinolytic activity was also found. These PMA-mediated alterations in MMP-2 mRNA levels were independent of de novo protein synthesis and involved both transcriptional and post-transcriptional events. Most notably, PMA regulates MMP-2 mRNA expression through a mechanism involving message de-stabilization. Additionally, protein kinase C mediated events were found to play a role(s) in the regulation of MMP-2 message expression in NR3 cells. This study demonstrates several novel aspects regarding the regulation of MMP-2 expression in a H-ras transformed cell line and thereby provides further insight into the altered growth regulatory programs associated with H-ras mediated cellular transformation.
Yeung
O
O
Department of Laboratory Medicine and Pathobiology, St. Michael's Hospital and the University of Toronto, Ontario, Canada.
Hurta
R A
RA
D000818:Animals; D015152:Blotting, Northern; D002273:Carcinogens; D002461:Cell Line, Transformed; D004586:Electrophoresis; D015972:Gene Expression Regulation, Neoplastic; D011905:Genes, ras / Q000235:genetics*; D015151:Immunoblotting; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D051379:Mice; D009369:Neoplasms / Q000201:enzymology / Q000209:etiology*; D010703:Phorbol Esters; D011485:Protein Binding; D011493:Protein Kinase C / Q000378:metabolism / Q000502:physiology; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D012333:RNA, Messenger / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate; D013997:Time Factors; D014158:Transcription, Genetic / Q000187:drug effects; D014407:Tumor Cells, Cultured
D002273:Carcinogens; D010703:Phorbol Esters; D011500:Protein Synthesis Inhibitors; D012333:RNA, Messenger; D011493:Protein Kinase C; D020778:Matrix Metalloproteinase 2; D013755:Tetradecanoylphorbol Acetate